论文部分内容阅读
2016年是十三五规划的开局之年,也是中国经济进入深度调整期和转型期的关键之年。创新作为医药行业供给侧改革的关键驱动力,需要知识产权为之保驾护航。随着医药科技繁荣发展,医药企业创新能力稳步提高,知识产权对医药科技创新和产业经济发展的支撑作用日益凸显。为了进一步贯彻实施国家知识产权战略和创新驱动发展战略,推动知识产权运用、保护工作服务医药产业创新、创造、创业,支撑经济发展新常态,加快医药创造大国和知识产权强国建设,中国药学会医药知
2016 is the first year of the 13th Five-Year Plan and also a crucial year for China’s economy to enter a period of deep readjustment and transition. Innovation, as the key driver of the supply-side reform of the pharmaceutical industry, requires the protection of intellectual property. With the flourishing development of medical science and technology, the innovative capability of pharmaceutical enterprises has been steadily increasing. The supporting role of intellectual property rights in pharmaceutical technological innovation and industrial economic development has become increasingly prominent. In order to further implement the national intellectual property strategy and innovation-driven development strategy, promote the use of intellectual property rights, protect the work to serve the pharmaceutical industry to innovate, create and start businesses, and support the new normal of economic development, speed up the building of a large pharmaceutical power and intellectual property powerhouse, the Chinese Pharmaceutical Association know